table of content
1 Study Coverage
1.1 Super Generic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Super Generic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Traditional Generic Drugs
1.2.3 Biosimilars
1.3 Market by Application
1.3.1 Global Super Generic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Super Generic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Super Generic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Super Generic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Super Generic Drugs Sales by Region
2.4.1 Global Super Generic Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Super Generic Drugs by Region (2023-2028)
2.5 Global Super Generic Drugs Revenue by Region
2.5.1 Global Super Generic Drugs Revenue by Region (2017-2022)
2.5.2 Global Super Generic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Super Generic Drugs Sales by Manufacturers
3.1.1 Global Top Super Generic Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Super Generic Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Super Generic Drugs in 2021
3.2 Global Super Generic Drugs Revenue by Manufacturers
3.2.1 Global Super Generic Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Super Generic Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Super Generic Drugs Revenue in 2021
3.3 Global Super Generic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Super Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Super Generic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Super Generic Drugs Sales by Type
4.1.1 Global Super Generic Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Super Generic Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Super Generic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Super Generic Drugs Revenue by Type
4.2.1 Global Super Generic Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Super Generic Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Super Generic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Super Generic Drugs Price by Type
4.3.1 Global Super Generic Drugs Price by Type (2017-2022)
4.3.2 Global Super Generic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Super Generic Drugs Sales by Application
5.1.1 Global Super Generic Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Super Generic Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Super Generic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Super Generic Drugs Revenue by Application
5.2.1 Global Super Generic Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Super Generic Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Super Generic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Super Generic Drugs Price by Application
5.3.1 Global Super Generic Drugs Price by Application (2017-2022)
5.3.2 Global Super Generic Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Super Generic Drugs Market Size by Type
6.1.1 North America Super Generic Drugs Sales by Type (2017-2028)
6.1.2 North America Super Generic Drugs Revenue by Type (2017-2028)
6.2 North America Super Generic Drugs Market Size by Application
6.2.1 North America Super Generic Drugs Sales by Application (2017-2028)
6.2.2 North America Super Generic Drugs Revenue by Application (2017-2028)
6.3 North America Super Generic Drugs Market Size by Country
6.3.1 North America Super Generic Drugs Sales by Country (2017-2028)
6.3.2 North America Super Generic Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Super Generic Drugs Market Size by Type
7.1.1 Europe Super Generic Drugs Sales by Type (2017-2028)
7.1.2 Europe Super Generic Drugs Revenue by Type (2017-2028)
7.2 Europe Super Generic Drugs Market Size by Application
7.2.1 Europe Super Generic Drugs Sales by Application (2017-2028)
7.2.2 Europe Super Generic Drugs Revenue by Application (2017-2028)
7.3 Europe Super Generic Drugs Market Size by Country
7.3.1 Europe Super Generic Drugs Sales by Country (2017-2028)
7.3.2 Europe Super Generic Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Super Generic Drugs Market Size by Type
8.1.1 Asia Pacific Super Generic Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Super Generic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Super Generic Drugs Market Size by Application
8.2.1 Asia Pacific Super Generic Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Super Generic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Super Generic Drugs Market Size by Region
8.3.1 Asia Pacific Super Generic Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Super Generic Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Super Generic Drugs Market Size by Type
9.1.1 Latin America Super Generic Drugs Sales by Type (2017-2028)
9.1.2 Latin America Super Generic Drugs Revenue by Type (2017-2028)
9.2 Latin America Super Generic Drugs Market Size by Application
9.2.1 Latin America Super Generic Drugs Sales by Application (2017-2028)
9.2.2 Latin America Super Generic Drugs Revenue by Application (2017-2028)
9.3 Latin America Super Generic Drugs Market Size by Country
9.3.1 Latin America Super Generic Drugs Sales by Country (2017-2028)
9.3.2 Latin America Super Generic Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Super Generic Drugs Market Size by Type
10.1.1 Middle East and Africa Super Generic Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Super Generic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Super Generic Drugs Market Size by Application
10.2.1 Middle East and Africa Super Generic Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Super Generic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Super Generic Drugs Market Size by Country
10.3.1 Middle East and Africa Super Generic Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Super Generic Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Corporation Information
11.2.2 Novartis - Sandoz Overview
11.2.3 Novartis - Sandoz Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis - Sandoz Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis - Sandoz Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Overview
11.4.3 Sun Pharmaceutical Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceutical Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Aspen
11.5.1 Aspen Corporation Information
11.5.2 Aspen Overview
11.5.3 Aspen Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Aspen Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aspen Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Corporation Information
11.6.2 Fresenius Kabi Overview
11.6.3 Fresenius Kabi Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Fresenius Kabi Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fresenius Kabi Recent Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Corporation Information
11.7.2 Pfizer (Hospira) Overview
11.7.3 Pfizer (Hospira) Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer (Hospira) Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer (Hospira) Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Aurobindo
11.9.1 Aurobindo Corporation Information
11.9.2 Aurobindo Overview
11.9.3 Aurobindo Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aurobindo Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aurobindo Recent Developments
11.10 Lupin
11.10.1 Lupin Corporation Information
11.10.2 Lupin Overview
11.10.3 Lupin Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lupin Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lupin Recent Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Corporation Information
11.11.2 Dr. Reddy's Overview
11.11.3 Dr. Reddy's Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dr. Reddy's Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Recent Developments
11.12 Apotex
11.12.1 Apotex Corporation Information
11.12.2 Apotex Overview
11.12.3 Apotex Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Apotex Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Apotex Recent Developments
11.13 Cipla
11.13.1 Cipla Corporation Information
11.13.2 Cipla Overview
11.13.3 Cipla Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Cipla Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cipla Recent Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Corporation Information
11.14.2 ENDO (Par Pharmaceutical) Overview
11.14.3 ENDO (Par Pharmaceutical) Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 ENDO (Par Pharmaceutical) Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 ENDO (Par Pharmaceutical) Recent Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Corporation Information
11.15.2 Stada Arzneimittel Overview
11.15.3 Stada Arzneimittel Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Stada Arzneimittel Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Stada Arzneimittel Recent Developments
11.16 Krka Group
11.16.1 Krka Group Corporation Information
11.16.2 Krka Group Overview
11.16.3 Krka Group Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Krka Group Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Krka Group Recent Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Corporation Information
11.17.2 Nichi-Iko Pharmaceutical Overview
11.17.3 Nichi-Iko Pharmaceutical Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Nichi-Iko Pharmaceutical Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Nichi-Iko Pharmaceutical Recent Developments
11.18 Valeant
11.18.1 Valeant Corporation Information
11.18.2 Valeant Overview
11.18.3 Valeant Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Valeant Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Valeant Recent Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Corporation Information
11.19.2 Zydus Cadila Overview
11.19.3 Zydus Cadila Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Zydus Cadila Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Zydus Cadila Recent Developments
11.20 Hikma
11.20.1 Hikma Corporation Information
11.20.2 Hikma Overview
11.20.3 Hikma Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Hikma Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Hikma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Super Generic Drugs Industry Chain Analysis
12.2 Super Generic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Super Generic Drugs Production Mode & Process
12.4 Super Generic Drugs Sales and Marketing
12.4.1 Super Generic Drugs Sales Channels
12.4.2 Super Generic Drugs Distributors
12.5 Super Generic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Super Generic Drugs Industry Trends
13.2 Super Generic Drugs Market Drivers
13.3 Super Generic Drugs Market Challenges
13.4 Super Generic Drugs Market Restraints
14 Key Findings in The Global Super Generic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
